Hyundai ADM (187660) has 4 disclosed insider purchases and 0 disclosed disposals on record, filed by 1 distinct insiders. Together those filings cover ₩116M ($80K) in reported transaction value. The earliest filing StockDrifts holds for Hyundai ADM is dated 2011-11-05; the most recent is 2026-02-06. Across these filings the average return since disclosure is +541.40%, measured from each filing date to the latest available close.
| Date | Type | Source | Insider | Position | Shares | Price at filing | Return | Value |
|---|---|---|---|---|---|---|---|---|
| 2026-08-28 | BUY | Market Buy | 박차석 Park Cha-seok | Chief Technology Officer | 692 | ₩4,230 | +38.3% | ₩3M ($2K) |
| 2026-08-28 | BUY | 유상신주취득 | 현대바이오 Hyundai Bio | - | 2.2M | ₩4,230 | +38.3% | ₩6.9B ($4.8M) |
| 2026-08-28 | BUY | 유상신주취득 | 박차석 Park Cha-seok | Chief Technology Officer | 9.3K | ₩4,230 | +38.3% | ₩29M ($20K) |
| 2026-08-19 | SELL | 증여 | 박차석 Park Cha-seok | Chief Technology Officer | -10.0K | - | - | - |
| 2026-02-06 | BUY | Market Buy | 박차석 Park Cha-seok | Chief Technology Officer | 5.6K | ₩3,005 | +521.3% | ₩17M ($12K) |
| 2025-12-12 | BUY | Market Buy | 박차석 Park Cha-seok | Outside Director | 15.0K | ₩2,675 | +597.9% | ₩40M ($28K) |
| 2025-11-12 | BUY | Market Buy | 박차석 Park Cha-seok | Outside Director | 8.9K | ₩2,840 | +557.4% | ₩25M ($18K) |
| 2025-11-05 | SELL | 전환등 | 현대바이오 Hyundai Bio | - | -1.1M | ₩2,780 | -571.6% | ₩3.2B ($2.2M) |
| 2025-10-27 | BUY | CB인수 | 현대바이오 Hyundai Bio | - | 1.1M | ₩3,100 | +502.3% | ₩3.6B ($2.5M) |
| 2025-10-23 | BUY | Market Buy | 박차석 Park Cha-seok | Outside Director | 10.5K | ₩3,170 | +489.0% | ₩33M ($23K) |
| 2025-07-31 | BUY | 신규선임 | 박차석 Park Cha-seok | Chief Technology Officer | 10.0K | ₩1,486 | +1156.4% | ₩15M ($10K) |
| 2024-11-28 | BUY | 무상신주취득 | 현대바이오 Hyundai Bio | - | 6.6M | ₩1,651 | +1030.8% | ₩10.9B ($7.6M) |
| 2024-05-20 | BUY | 장외매수 | 현대바이오 Hyundai Bio | - | 6.6M | ₩1,825 | +923.0% | ₩12.1B ($8.4M) |
| 2024-05-20 | SELL | 장외매도 | 모비스 Mobis | - | -7.6M | ₩1,825 | -923.0% | ₩13.9B ($9.7M) |
| 2011-11-05 | BUY | 전환사채의권리행사 | 현대바이오 Hyundai Bio | - | 1.1M | - | - | - |
Every trade listed above comes from an official regulatory disclosure. For how StockDrifts scores these disclosures, see the Korea insider signal tier research, or browse every Korean stock we track.